If you are looking to manage your precision oncology program in your own laboratory, Imagia Canexia Health’s proprietary software platform puts the control back in your hands without the need for costly infrastructure overhead.
The Imagia Canexia Health Insights Platform seamlessly integrates with your internal systems to provide an accurate and high-throughput suite for molecular and computational genome analysis, quality assurance, interpretation, and report generation from targeted next-generation sequencing (NGS) data at the individual level.
The fully automated scalable system provides the security, traceability, data management, and performance required for NGS data analysis in a clinical setting.
The Imagia Canexia Health Insights Platform provides analysis from targeted NGS data for individual cancer patients. Data is analyzed to identify genomic variants and recommend treatment options, including any matching clinical trials. A draft report is created and reviewed by an accredited geneticist before the final report is approved.
Each report includes carefully vetted recommendations for consideration, provided in the context of a primary cancer type.
Imagia Canexia Health’s therapeutic recommendations are based on gene mutations and the clinical data provided.
Clinical trials included have been reviewed and selected by certified clinical molecular geneticists.
Don’t miss out on news, webinars, and other resources from Imagia Canexia Health. Subscribe to our mailing list to stay up to date on the latest. You can opt-out at any time.
Imagia Canexia Health’s Find It & Fusions panels detect mutations and gene fusion events in solid tumor tissue. Tissue profiling can be used to help inform treatment decisions or predict progression of cancer based on somatic mutations found in the tumor.
Imagia Canexia Health’s Follow It panel detects mutations in plasma. Plasma profiling (a type of liquid biopsy) can be used to help tailor treatment, monitor cancer progression, or detect treatment resistance.
Contact us to schedule time with one of our PhD-level Customer Success team members.